புத்துயிர் பெறுங்கள் பயோமெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs
02-Mar-2021
Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products
Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products
Heusden-Zolder, Belgium, 2 March 2021 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing prescription drugs for age-related diseases, announces it has completed a EUR 3.2 million Series A round. The funding is being used to advance the development of Rejuvenate’s lead candidate RJx-01 in both acute and chronic sarcopenia (disuse-induced and age-related muscle failure).
The financing included lead investor Vesalius Biocapital III and private non-disclosed investors, as well as existing investors. Additionally, Rejuvenate gratefully acknowledges the ongoing support of Flanders Innovation and Entrepreneurship (VLAIO) in non-dilutive funding. Concurrent with t ....

Eric Verdin , Bart Braeckman , Jean Yves Reginster , Ann Beli , Johan Auwerx , Andrea Maier , Marco Sandri , Rejuvenate Biomed Secures , Advance Development , Healthy Aging , Rejuvenate Biomed , Vesalius Biocapital , Flanders Innovation , Managing Partner , எரிக் வெர்டின் , ஆண்டு பெலி , ஆண்ட்ரியா மேயையர் , மார்கோ சாண்ட்ரி , புத்துயிர் பெறுங்கள் பயோமெட் , ஃப்ல்யாஂட்ஸ் கண்டுபிடிப்பு , நிர்வகித்தல் கூட்டாளர் ,